Cargando…
The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish
3,4-Methylenedioxymethamphetamine (MDMA) and its derivatives, 2,5-dimethoxy-4-bromo-amphetamine hydrobromide (DOB) and para-methoxyamphetamine (PMA), are recreational drugs whose pharmacological effects have recently been attributed to serotonin 5HT(2A/C) receptors. However, there is growing evidenc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557732/ https://www.ncbi.nlm.nih.gov/pubmed/28855876 http://dx.doi.org/10.3389/fpsyt.2017.00146 |
_version_ | 1783257253826002944 |
---|---|
author | Ponzoni, Luisa Braida, Daniela Bondiolotti, Gianpietro Sala, Mariaelvina |
author_facet | Ponzoni, Luisa Braida, Daniela Bondiolotti, Gianpietro Sala, Mariaelvina |
author_sort | Ponzoni, Luisa |
collection | PubMed |
description | 3,4-Methylenedioxymethamphetamine (MDMA) and its derivatives, 2,5-dimethoxy-4-bromo-amphetamine hydrobromide (DOB) and para-methoxyamphetamine (PMA), are recreational drugs whose pharmacological effects have recently been attributed to serotonin 5HT(2A/C) receptors. However, there is growing evidence that the oxytocin (OT)/vasopressin system can modulate some the effects of MDMA. In this study, MDMA (2.5–10 mg/kg), DOB (0.5 mg/kg), or PMA (0.005, 0.1, or 0.25 mg/kg) were administered intramuscularly to adult zebra fish, alone or in combination with the V(1a) vasopressin antagonist, SR49059 (0.01–1 ng/kg), before carrying out conditioned place preference (CPP), social preference, novel tank diving, and light–dark tests in order to evaluate subsequent rewarding, social, and emotional-like behavior. The combination of SR49059 and each drug progressively blocked: (1) rewarding behavior as measured by CPP in terms of time spent in drug-paired compartment; (2) prosocial effects measured on the basis of the time spent in the proximity of a nacre fish picture; and (3) anxiolytic effects in terms of the time spent in the upper half of the novel tank and in the white compartment of the tank used for the light–dark test. Antagonism was obtained at SR49059 doses which, when given alone, did not change motor function. In comparison with a control group, receiving vehicle alone, there was a three to five times increase in the brain release of isotocin (the analog of OT in fish) after treatment with the most active doses of MDMA (10 mg/kg), DOB (0.5 mg/kg), and PMA (0.1 mg/kg) as evaluated by means of bioanalytical reversed-phase high-performance liquid chromatography. Taken together, these findings show that the OT/vasopressin system is involved in the rewarding, prosocial, and anxiolytic effects of MDMA, DOB, and PMA in zebra fish and underline the association between this system and the behavioral alterations associated with disorders related to substance abuse. |
format | Online Article Text |
id | pubmed-5557732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-55577322017-08-30 The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish Ponzoni, Luisa Braida, Daniela Bondiolotti, Gianpietro Sala, Mariaelvina Front Psychiatry Psychiatry 3,4-Methylenedioxymethamphetamine (MDMA) and its derivatives, 2,5-dimethoxy-4-bromo-amphetamine hydrobromide (DOB) and para-methoxyamphetamine (PMA), are recreational drugs whose pharmacological effects have recently been attributed to serotonin 5HT(2A/C) receptors. However, there is growing evidence that the oxytocin (OT)/vasopressin system can modulate some the effects of MDMA. In this study, MDMA (2.5–10 mg/kg), DOB (0.5 mg/kg), or PMA (0.005, 0.1, or 0.25 mg/kg) were administered intramuscularly to adult zebra fish, alone or in combination with the V(1a) vasopressin antagonist, SR49059 (0.01–1 ng/kg), before carrying out conditioned place preference (CPP), social preference, novel tank diving, and light–dark tests in order to evaluate subsequent rewarding, social, and emotional-like behavior. The combination of SR49059 and each drug progressively blocked: (1) rewarding behavior as measured by CPP in terms of time spent in drug-paired compartment; (2) prosocial effects measured on the basis of the time spent in the proximity of a nacre fish picture; and (3) anxiolytic effects in terms of the time spent in the upper half of the novel tank and in the white compartment of the tank used for the light–dark test. Antagonism was obtained at SR49059 doses which, when given alone, did not change motor function. In comparison with a control group, receiving vehicle alone, there was a three to five times increase in the brain release of isotocin (the analog of OT in fish) after treatment with the most active doses of MDMA (10 mg/kg), DOB (0.5 mg/kg), and PMA (0.1 mg/kg) as evaluated by means of bioanalytical reversed-phase high-performance liquid chromatography. Taken together, these findings show that the OT/vasopressin system is involved in the rewarding, prosocial, and anxiolytic effects of MDMA, DOB, and PMA in zebra fish and underline the association between this system and the behavioral alterations associated with disorders related to substance abuse. Frontiers Media S.A. 2017-08-14 /pmc/articles/PMC5557732/ /pubmed/28855876 http://dx.doi.org/10.3389/fpsyt.2017.00146 Text en Copyright © 2017 Ponzoni, Braida, Bondiolotti and Sala. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Ponzoni, Luisa Braida, Daniela Bondiolotti, Gianpietro Sala, Mariaelvina The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
title | The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
title_full | The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
title_fullStr | The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
title_full_unstemmed | The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
title_short | The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish |
title_sort | non-peptide arginine-vasopressin v(1a) selective receptor antagonist, sr49059, blocks the rewarding, prosocial, and anxiolytic effects of 3,4-methylenedioxymethamphetamine and its derivatives in zebra fish |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557732/ https://www.ncbi.nlm.nih.gov/pubmed/28855876 http://dx.doi.org/10.3389/fpsyt.2017.00146 |
work_keys_str_mv | AT ponzoniluisa thenonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish AT braidadaniela thenonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish AT bondiolottigianpietro thenonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish AT salamariaelvina thenonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish AT ponzoniluisa nonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish AT braidadaniela nonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish AT bondiolottigianpietro nonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish AT salamariaelvina nonpeptideargininevasopressinv1aselectivereceptorantagonistsr49059blockstherewardingprosocialandanxiolyticeffectsof34methylenedioxymethamphetamineanditsderivativesinzebrafish |